# Qualcomm Inc: financial statements, quarterly

QCOM · Nasdaq · CIK 804328 · [Technology](/sectors/technology.md) · fiscal year ends Sep 27

Pages: [Overview](/companies/qcom.md) · [Financials](/companies/qcom/financials.md) · [Filings](/companies/qcom/filings.md) · [Insiders](/companies/qcom/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qcom/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-24) | Q1 FY2024 (2023-12-24) | Q2 FY2024 (2024-03-24) | Q3 FY2024 (2024-06-23) | Q4 FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [8.6 d](/filings/0000804328-25-000085.md) | [9.9](/filings/0000804328-25-000011.md) | [9.4](/filings/0000804328-25-000031.md) | [9.4](/filings/0000804328-25-000045.md) | [10.2 d](/filings/0000804328-25-000085.md) | [11.7](/filings/0000804328-26-000017.md) | [11.0](/filings/0000804328-26-000061.md) | [10.4](/filings/0000804328-26-000086.md) | [11.3 d](/filings/0000804328-25-000085.md) | [12.3](/filings/0000804328-26-000017.md) | [10.6](/filings/0000804328-26-000061.md) | [9.9](/filings/0000804328-26-000086.md) |
| Cost of revenue | $bn | [3.9 d](/filings/0000804328-25-000085.md) | [4.3](/filings/0000804328-25-000011.md) | [4.1](/filings/0000804328-25-000031.md) | [4.2](/filings/0000804328-25-000045.md) | [4.5 d](/filings/0000804328-25-000085.md) | [5.2](/filings/0000804328-26-000017.md) | [4.9](/filings/0000804328-26-000061.md) | [4.6](/filings/0000804328-26-000086.md) | [5.0 d](/filings/0000804328-25-000085.md) | [5.6](/filings/0000804328-26-000017.md) | [4.9](/filings/0000804328-26-000061.md) | [4.7](/filings/0000804328-26-000086.md) |
| Research and development | $bn | [2.1 d](/filings/0000804328-25-000085.md) | [2.1](/filings/0000804328-25-000011.md) | [2.2](/filings/0000804328-25-000031.md) | [2.3](/filings/0000804328-25-000045.md) | [2.3 d](/filings/0000804328-25-000085.md) | [2.2](/filings/0000804328-26-000017.md) | [2.2](/filings/0000804328-26-000061.md) | [2.2](/filings/0000804328-26-000086.md) | [2.4 d](/filings/0000804328-25-000085.md) | [2.5](/filings/0000804328-26-000017.md) | [2.5](/filings/0000804328-26-000061.md) | [2.6](/filings/0000804328-26-000086.md) |
| Selling, general and administrative | $bn | [0.6 d](/filings/0000804328-25-000085.md) | [0.6](/filings/0000804328-25-000011.md) | [0.7](/filings/0000804328-25-000031.md) | [0.7](/filings/0000804328-25-000045.md) | [0.8 d](/filings/0000804328-25-000085.md) | [0.7](/filings/0000804328-26-000017.md) | [0.7](/filings/0000804328-26-000061.md) | [0.8](/filings/0000804328-26-000086.md) | [0.9 d](/filings/0000804328-25-000085.md) | [0.9](/filings/0000804328-26-000017.md) | [0.9](/filings/0000804328-26-000061.md) | [1.0](/filings/0000804328-26-000086.md) |
| Operating income | $bn | [1.4 d](/filings/0000804328-25-000085.md) | [2.9](/filings/0000804328-25-000011.md) | [2.3](/filings/0000804328-25-000031.md) | [2.2](/filings/0000804328-25-000045.md) | [2.6 d](/filings/0000804328-25-000085.md) | [3.6](/filings/0000804328-26-000017.md) | [3.1](/filings/0000804328-26-000061.md) | [2.8](/filings/0000804328-26-000086.md) | [2.9 d](/filings/0000804328-25-000085.md) | [3.4](/filings/0000804328-26-000017.md) | [2.3](/filings/0000804328-26-000061.md) | [1.6](/filings/0000804328-26-000086.md) |
| Interest expense | $bn | [0.2 d](/filings/0000804328-25-000085.md) | [0.2](/filings/0000804328-25-000011.md) | [0.2](/filings/0000804328-25-000031.md) | [0.2](/filings/0000804328-25-000045.md) | [0.2 d](/filings/0000804328-25-000085.md) | [0.2](/filings/0000804328-26-000017.md) | [0.2](/filings/0000804328-26-000061.md) | [0.2](/filings/0000804328-26-000086.md) | [0.2 d](/filings/0000804328-25-000085.md) | [0.2](/filings/0000804328-26-000017.md) | [0.2](/filings/0000804328-26-000061.md) | [0.2](/filings/0000804328-26-000086.md) |
| Income tax | $bn | [(0.2) d](/filings/0000804328-25-000085.md) | [0.2](/filings/0000804328-25-000011.md) | [0.2](/filings/0000804328-25-000031.md) | [0.2](/filings/0000804328-25-000045.md) | [(0.3) d](/filings/0000804328-25-000085.md) | [0.5](/filings/0000804328-26-000017.md) | [0.3](/filings/0000804328-26-000061.md) | [0.3](/filings/0000804328-26-000086.md) | [6.1 d](/filings/0000804328-25-000085.md) | [0.5](/filings/0000804328-26-000017.md) | [(5.1)](/filings/0000804328-26-000061.md) | [0.5](/filings/0000804328-26-000086.md) |
| Net income | $bn | [1.5 d](/filings/0000804328-25-000085.md) | [2.8](/filings/0000804328-25-000011.md) | [2.3](/filings/0000804328-25-000031.md) | [2.1](/filings/0000804328-25-000045.md) | [2.9 d](/filings/0000804328-25-000085.md) | [3.2](/filings/0000804328-26-000017.md) | [2.8](/filings/0000804328-26-000061.md) | [2.7](/filings/0000804328-26-000086.md) | [(3.1) d](/filings/0000804328-25-000085.md) | [3.0](/filings/0000804328-26-000017.md) | [7.4](/filings/0000804328-26-000061.md) | [2.0](/filings/0000804328-26-000086.md) |
| Diluted EPS | $ per share | not reported | [2.46](/filings/0000804328-25-000011.md) | [2.06](/filings/0000804328-25-000031.md) | [1.88](/filings/0000804328-25-000045.md) | not reported | [2.83](/filings/0000804328-26-000017.md) | [2.52](/filings/0000804328-26-000061.md) | [2.43](/filings/0000804328-26-000086.md) | not reported | [2.78](/filings/0000804328-26-000017.md) | [6.88](/filings/0000804328-26-000061.md) | [1.87](/filings/0000804328-26-000086.md) |
| Basic EPS | $ per share | not reported | [2.48](/filings/0000804328-25-000011.md) | [2.08](/filings/0000804328-25-000031.md) | [1.91](/filings/0000804328-25-000045.md) | not reported | [2.86](/filings/0000804328-26-000017.md) | [2.55](/filings/0000804328-26-000061.md) | [2.44](/filings/0000804328-26-000086.md) | not reported | [2.81](/filings/0000804328-26-000017.md) | [6.92](/filings/0000804328-26-000061.md) | [1.89](/filings/0000804328-26-000086.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-24) | Q1 FY2024 (2023-12-24) | Q2 FY2024 (2024-03-24) | Q3 FY2024 (2024-06-23) | FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [8.5](/filings/0000804328-24-000075.md) | [8.1](/filings/0000804328-24-000017.md) | [9.2](/filings/0000804328-24-000039.md) | [7.8](/filings/0000804328-24-000056.md) | [7.8](/filings/0000804328-25-000085.md) | [8.7](/filings/0000804328-25-000011.md) | [7.2](/filings/0000804328-25-000031.md) | [5.4](/filings/0000804328-25-000045.md) | [5.5](/filings/0000804328-26-000086.md) | [7.2](/filings/0000804328-26-000017.md) | [5.4](/filings/0000804328-26-000061.md) | [4.5](/filings/0000804328-26-000086.md) |
| Current assets | $bn | [22.5](/filings/0000804328-24-000075.md) | [23.4](/filings/0000804328-24-000017.md) | [24.2](/filings/0000804328-24-000039.md) | [23.3](/filings/0000804328-24-000056.md) | [25.2](/filings/0000804328-25-000085.md) | [26.1](/filings/0000804328-25-000011.md) | [26.1](/filings/0000804328-25-000031.md) | [24.9](/filings/0000804328-25-000045.md) | [25.8](/filings/0000804328-26-000086.md) | [24.6](/filings/0000804328-26-000017.md) | [23.1](/filings/0000804328-26-000061.md) | [23.0](/filings/0000804328-26-000086.md) |
| Total assets | $bn | [51.0](/filings/0000804328-24-000075.md) | [52.1](/filings/0000804328-24-000017.md) | [53.2](/filings/0000804328-24-000039.md) | [52.7](/filings/0000804328-24-000056.md) | [55.2](/filings/0000804328-25-000085.md) | [55.6](/filings/0000804328-25-000011.md) | [55.4](/filings/0000804328-25-000031.md) | [54.9](/filings/0000804328-25-000045.md) | [50.1](/filings/0000804328-26-000086.md) | [53.0](/filings/0000804328-26-000017.md) | [57.1](/filings/0000804328-26-000061.md) | [57.4](/filings/0000804328-26-000086.md) |
| Current liabilities | $bn | [9.6](/filings/0000804328-24-000075.md) | [9.2](/filings/0000804328-24-000017.md) | [9.1](/filings/0000804328-24-000039.md) | [9.7](/filings/0000804328-24-000056.md) | [10.5](/filings/0000804328-25-000085.md) | [10.0](/filings/0000804328-25-000011.md) | [9.5](/filings/0000804328-25-000031.md) | [7.8](/filings/0000804328-25-000045.md) | [9.1](/filings/0000804328-26-000086.md) | [9.8](/filings/0000804328-26-000017.md) | [9.8](/filings/0000804328-26-000061.md) | [11.4](/filings/0000804328-26-000086.md) |
| Total liabilities | $bn | [29.5](/filings/0000804328-24-000075.md) | [29.1](/filings/0000804328-24-000017.md) | [28.7](/filings/0000804328-24-000039.md) | [28.1](/filings/0000804328-24-000056.md) | [28.9](/filings/0000804328-25-000085.md) | [28.7](/filings/0000804328-25-000011.md) | [27.6](/filings/0000804328-25-000031.md) | [27.7](/filings/0000804328-25-000045.md) | [28.9](/filings/0000804328-26-000086.md) | [30.0](/filings/0000804328-26-000017.md) | [29.9](/filings/0000804328-26-000061.md) | [29.7](/filings/0000804328-26-000086.md) |
| Long-term debt | $bn | [14.5](/filings/0000804328-24-000075.md) | [14.6](/filings/0000804328-24-000017.md) | [14.5](/filings/0000804328-24-000039.md) | [13.2](/filings/0000804328-24-000056.md) | [13.3](/filings/0000804328-25-000085.md) | [13.2](/filings/0000804328-25-000011.md) | [13.3](/filings/0000804328-25-000031.md) | [14.8](/filings/0000804328-25-000045.md) | [14.8](/filings/0000804328-25-000085.md) | [14.8](/filings/0000804328-26-000017.md) | [14.8](/filings/0000804328-26-000061.md) | [12.8](/filings/0000804328-26-000086.md) |
| Current portion of debt | $bn | [0.9](/filings/0000804328-24-000075.md) | [0.9](/filings/0000804328-24-000017.md) | [0.9](/filings/0000804328-24-000039.md) | [1.4](/filings/0000804328-24-000056.md) | [1.4](/filings/0000804328-25-000085.md) | [1.4](/filings/0000804328-25-000011.md) | [1.4](/filings/0000804328-25-000031.md) | [0.0](/filings/0000804328-25-000045.md) | [0.0](/filings/0000804328-26-000086.md) | not reported | [0.5](/filings/0000804328-26-000061.md) | [2.0](/filings/0000804328-26-000086.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0000804328-26-000086.md) | not reported | not reported | [0.5](/filings/0000804328-26-000086.md) |
| Shareholders' equity | $bn | [21.6](/filings/0000804328-25-000085.md) | [23.1](/filings/0000804328-25-000031.md) | [24.5](/filings/0000804328-25-000045.md) | [24.7](/filings/0000804328-25-000045.md) | [26.3](/filings/0000804328-26-000086.md) | [26.9](/filings/0000804328-26-000061.md) | [27.7](/filings/0000804328-26-000086.md) | [27.2](/filings/0000804328-26-000086.md) | [21.2](/filings/0000804328-26-000086.md) | [23.1](/filings/0000804328-26-000061.md) | [27.3](/filings/0000804328-26-000086.md) | [27.7](/filings/0000804328-26-000086.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent, us-gaap:DebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-24) | Q1 FY2024 (2023-12-24) | Q2 FY2024 (2024-03-24) | Q3 FY2024 (2024-06-23) | Q4 FY2024 (2024-09-29) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-28) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4,090 d](/filings/0000804328-25-000085.md) | [2,949](/filings/0000804328-25-000011.md) | [3,554 d](/filings/0000804328-25-000031.md) | [3,052 d](/filings/0000804328-25-000045.md) | [2,647 d](/filings/0000804328-25-000085.md) | [4,587](/filings/0000804328-26-000017.md) | [2,554 d](/filings/0000804328-26-000061.md) | [2,875 d](/filings/0000804328-26-000086.md) | [3,996 d](/filings/0000804328-25-000085.md) | [4,965](/filings/0000804328-26-000017.md) | [2,449 d](/filings/0000804328-26-000061.md) | [991 d](/filings/0000804328-26-000086.md) |
| Capital expenditure | $m | [293 d](/filings/0000804328-25-000085.md) | [214](/filings/0000804328-25-000011.md) | [184 d](/filings/0000804328-25-000031.md) | [387 d](/filings/0000804328-25-000045.md) | [256 d](/filings/0000804328-25-000085.md) | [277](/filings/0000804328-26-000017.md) | [214 d](/filings/0000804328-26-000061.md) | [294 d](/filings/0000804328-26-000086.md) | [407 d](/filings/0000804328-25-000085.md) | [549](/filings/0000804328-26-000017.md) | [533 d](/filings/0000804328-26-000061.md) | [496 d](/filings/0000804328-26-000086.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [400 d](/filings/0000804328-25-000085.md) | [784](/filings/0000804328-25-000011.md) | [731 d](/filings/0000804328-25-000031.md) | [1,303 d](/filings/0000804328-25-000045.md) | [1,303 d](/filings/0000804328-25-000085.md) | [1,750](/filings/0000804328-26-000017.md) | [1,748 d](/filings/0000804328-26-000061.md) | [2,849 d](/filings/0000804328-26-000086.md) | [2,444 d](/filings/0000804328-25-000085.md) | [2,650](/filings/0000804328-26-000017.md) | [2,792 d](/filings/0000804328-26-000061.md) | [1,364 d](/filings/0000804328-26-000086.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-25) | Q2 FY2023 (2023-03-26) | Q3 FY2023 (2023-06-25) | Q1 FY2024 (2023-12-24) | Q2 FY2024 (2024-03-24) | Q3 FY2024 (2024-06-23) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,131](/filings/0000804328-24-000017.md) | [1,123](/filings/0000804328-24-000039.md) | [1,124](/filings/0000804328-24-000056.md) | [1,127](/filings/0000804328-25-000011.md) | [1,130](/filings/0000804328-25-000031.md) | [1,134](/filings/0000804328-25-000045.md) | [1,122](/filings/0000804328-26-000017.md) | [1,115](/filings/0000804328-26-000061.md) | [1,099](/filings/0000804328-26-000086.md) | [1,079](/filings/0000804328-26-000017.md) | [1,072](/filings/0000804328-26-000061.md) | [1,069](/filings/0000804328-26-000086.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,050,000,000 at 2026-07-27, from the cover of the [10-Q filed 2026-07-29](/filings/0000804328-26-000086.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:24 ET. No prices; not investment advice.